Neuroscientist-turned science illustrator Radhika Patnala transforms cell biology into vivid landscapes, highlighting ...
On Thursday, OpenAI announced it had developed a large language model specifically trained on common biology workflows.
Nanomedicine prompts RNA to make protein-based drugs to treat diseases. Now we can fine-tune protein production by dialling ...
In the race of innovative drug R&D, whether for antibodies, peptides, or novel binding proteins, the efficiency of early-stage molecule discovery is always the key factor determining project success ...
Tomato yellow leaf curl disease (TYLCD), caused by begomoviruses, is a global problem in tomato production, affecting yield.
Explore the decades-long journey to map the full human genome, from early breakthroughs to the first complete, gapless DNA ...
Rather than representing a distinct gene product, this peptide arises from alternative splicing events within the IGF-1 gene locus, leading to a unique E-domain sequence with properties that diverge f ...
Zacks Investment Research on MSN
RVTY unveils Signals BioDesign for faster molecular cloning & R&D data
Revvity, Inc. RVTY announced the launch of Signals BioDesign, a cloud-based molecular cloning platform, under its Revvity ...
Explore 25 biology facts the future will forget as science evolves. From DNA's 'blueprint' to mitochondria's 'powerhouse,' ...
Stepping outside the classroom and into the world of research, Alfred University students recently had the opportunity to ...
Researchers have identified a novel therapeutic approach for colorectal cancer by exploiting a specific genetic vulnerability found in a majority of patients. The study focuses on the adenomatous ...
OpenAI’s GPT can summarize research papers and make predictions—but can it do science? Can it generate hypotheses, design experiments, interpret results and iterate? Last summer researchers at OpenAI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results